Raynaud’s Syndrome and Botox

Clinical Trials For BOTOX® Study

Southern Illinois University School of Medicine is currently recruiting Raynaud’s patients to participate in a clinical trial of BOTOX® therapy for chronic pain and ulcerations.  This is a 28-day randomized, double-blind, placebo-controlled clinical trial requiring travel to the clinic in Springfield, Illinois.